Consideration in treatment decisions for refractory Mycoplasma pneumoniae pneumonia
Mycoplasma pneumoniae (MP) is the most common cause of childhood bacterial pneumonia. Although macrolide is known to be effective as a first-line therapy, the proportion of macrolide resistance in MP pneumonia has strikingly increased during recent 2 decades in East Asia. This is challenging to phys...
Saved in:
Main Author: | Hye-Kyung Cho (Author) |
---|---|
Format: | Book |
Published: |
The Korean Pediatric Society,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Construction of a Nomogram for Identifying Refractory Mycoplasma pneumoniae Pneumonia Among Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children
by: Xie Q, et al.
Published: (2022) -
Acetylcysteine and budesonide for the treatment of refractory Mycoplasma pneumoniae pneumonia in children: a clinical observation
by: Yanli Wang, et al.
Published: (2023) -
Development of a Nomogram for Predicting Refractory Mycoplasma pneumoniae Pneumonia in Children
by: Fangfang Shen, et al.
Published: (2022) -
Correlation between Mycoplasma pneumoniae drug resistance and clinical characteristics in bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia
by: Xiao-Wen Zhan, et al.
Published: (2022) -
A Case of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Pregnancy Treated with Garenoxacin
by: Yoko Matsuda, et al.
Published: (2017)